A Phase IB/II study of nivolumab in combination with ALT

Project: Research project

Description

A Phase IB/II study of nivolumab in combination with ALT-803 in patients with pretreated, advanced or metastatic non-small cell lung cance
StatusActive
Effective start/end date2/1/163/30/21

Funding

  • Medical University of South Carolina

Fingerprint

Lung
ALT-803
nivolumab